Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Noble

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Aging Cell|January 13, 2022
Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementiaPatricia Gomez-Suaga, Gábor M Mórotz, Andrea Markovinovic, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
Brain, Behavior, and Immunity|September 16, 2023
P2X<sub>7</sub>R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytesPaula Beltran-Lobo, Martina M Hughes, Claire Troakes, et al.
Plos Genetics|March 3, 2017
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's diseaseFiona Kerr, Oyinkan Sofola-Adesakin, Dobril K Ivanov, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 2005
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinasePascal Derkinderen, Timothy M E Scales, Diane P Hanger, et al.
Journal of Neurochemistry|August 9, 2007
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progressionAdam R Cole, Wendy Noble, Lidy van Aalten, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2023
Artificial intelligence for neurodegenerative experimental modelsSarah J Marzi, Brian M Schilder, Alexi Nott, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Aging Cell|January 13, 2022
Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementiaPatricia Gomez-Suaga, Gábor M Mórotz, Andrea Markovinovic, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
Brain, Behavior, and Immunity|September 16, 2023
P2X<sub>7</sub>R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytesPaula Beltran-Lobo, Martina M Hughes, Claire Troakes, et al.
Plos Genetics|March 3, 2017
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's diseaseFiona Kerr, Oyinkan Sofola-Adesakin, Dobril K Ivanov, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 2005
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinasePascal Derkinderen, Timothy M E Scales, Diane P Hanger, et al.
Journal of Neurochemistry|August 9, 2007
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progressionAdam R Cole, Wendy Noble, Lidy van Aalten, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2023
Artificial intelligence for neurodegenerative experimental modelsSarah J Marzi, Brian M Schilder, Alexi Nott, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
Pageof 8